The Global Hemophilia Treatment Market accounted for US$ 12.45 billion in 2020 and is estimated to be US$ 22.41 billion by 2030 and is anticipated to register a CAGR of 6.1%. Hemophilia is an inherited genetic disorder which disables the body’s ability to make blood clots, a very important process needed to stop bleeding. Hence, Hemophilia leads to uncontrolled bleeding after the injury and can event lead to death. The main type of hemophilia are hemophilia A, and hemophilia B, and hemophilia A occurs due to deficiency of clotting factor VIII and hemophilia B, occurs deficiency of clotting factor IX. Hemophilia is generally treated with genetically engineered clotting factor medicines which prevent and treat prolonged bleeding. According to the Centers of Disease Control and Prevention, Hemophilia A affects 1 in 5,000 male births and around 400 babies are born with hemophilia A each year. According to the same source currently, the number of people with hemophilia in the U.S is estimated to be about 20,000.
The report “ Global Hemophilia Treatment Market, By Product (Recombinant coagulation factor concentrates, Plasma derived coagulation factor concentrates, Antifibrinolytic agents, and Desmopressin), By Disease Type (Hemophilia A, Hemophilia B, and Hemophilia C) By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospitals, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Trends, Analysis and Forecast till 2030”
Key Highlights:
- In 2020, Novo Nordisk has announced the launch of ESPEROCT, the company’s long-acting recombinant factor VIII product for the prevention and treatment of bleeding in individuals with hemophilia A. The new therapy is specifically indicated for routine prophylaxis to reduce the frequency of bleeding episodes, on-demand treatment, control of bleeding episodes and perioperative management of bleeding.
- In 2020, The U.S. Food and Drug Administration approved Sevenfact [coagulation factor VIIa (recombinant)-jncw] for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors (neutralizing antibodies). Sevenfact contains an active ingredient expressed in genetically engineered rabbits.
Analyst View:
Key players in the market are focusing on gaining approval of its novel hemophilia treatment drugs in key regions such as Europe and Asia-Pacific. Approval of such drugs in key regions is expected to fuel market growth over forecast period. For instance, in August 2018, Bayer AG’s hemophilia treatment drug Jivi received approval in Europe and in September 2018, Jivi also received approval in Japan.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Hemophilia Treatment Market, By Product (Recombinant coagulation factor concentrates, Plasma derived coagulation factor concentrates, Antifibrinolytic agents, and Desmopressin), By Disease Type (Hemophilia A, Hemophilia B, and Hemophilia C) By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospitals, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Trends, Analysis and Forecast till 2030”
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Hemophilia-Treatment-Market-By-121
Key Market Insights from the report:
The Global Hemophilia Treatment Market accounted for US$ 12.45 billion in 2020 and is estimated to be US$ 22.41 billion by 2030 and is anticipated to register a CAGR of 6.1%. The global hemophilia treatment market has been segmented on the basis of drug type, disease type, distribution channel and region.
- By Drug Type, the market is segmented into drug type, recombinant coagulation factor concentrates, plasma derived coagulation factor concentrates, antifibrinolytic agents, and desmopressi.
- By Disease Type, the market is segmented into Hemophilia A, Hemophilia B, and Hemophilia C.
- By Distribution Channel, the market is segmented into retail pharmacies, online pharmacies, and hospitals.
- By Region, the Global Diabetic Neuropathy Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape:
Key players operating in the global hemophilia treatment market includes Baxter International, Inc., Hospira, Inc., Baxalta, Novo Nordisk, BiogenInc., Pfizer, Inc., Bayer AG, CSL Behring, Chugai Pharmaceutical Co., Ferring B.V., Genentech, Inc., Kedrion, Octapharma AG, Sanofi SA, Shire Plc., and Swedish Orphan Biovitrum AB.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
Some Important Points Answered in this Market Report Are Given Below:
- Explains an overview of the product portfolio, including product development, planning, and positioning.
- Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
- Detailed analysis of the market revenue over the forecasted period.
- Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
- Study on the segments that are anticipated to dominate the market.
- Study on the regional analysis that is expected to register the highest growth over the forecast period.
Key Topics Covered
- Introduction
- Study Deliverables
- Study Assumptions
- Scope of the Study
- Research Methodology
- Executive Summary
- Opportunity Map Analysis
- Market at Glance
- Market Share (%) and BPS Analysis, by Region
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Investment Analysis
- Competitive Analysis
To know more
Contact Us:
Sales
Prophecy Market Insights
1 860 531 2701
Email- sales@prophecymarketinsights.com
